Post‑infectious ST elevation myocardial infarction following a COVID‑19 infection: A case report

Ceccarelli,Manuela; Marino,Andrea; Cosentino,Federica; Moscatt,Vittoria; Celesia,Benedetto Maurizio; Gussio,Maria; Bruno,Roberto; Rullo,Emmanuele Venanzi; Nunnari,Giuseppe; Cacopardo,Bruno Santi

doi:10.3892/br.2021.1493

Post‑infectious ST elevation myocardial infarction following a COVID‑19 infection: A case report

Authors:
- Manuela Ceccarelli
- Andrea Marino
- Federica Cosentino
- Vittoria Moscatt
- Benedetto Maurizio Celesia
- Maria Gussio
- Roberto Bruno
- Emmanuele Venanzi Rullo
- Giuseppe Nunnari
- Bruno Santi Cacopardo
View Affiliations

Affiliations: Unit of Infectious Diseases, ARNAS Garibaldi, Nesima Hospital, Department of Clinical and Experimental Medicine, University of Catania, I‑95122 Catania, Sicily, Italy, Unit of Infectious Diseases, Department of Clinical and Experimental Medicine, University of Messina, I‑I98124 Messina, Italy
Published online on: December 15, 2021 https://doi.org/10.3892/br.2021.1493
Article Number: 10

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Severe Acute Respiratory Syndrome‑Coronavirus‑2 (SARS‑CoV‑2) has been shown to increase the risk of thrombotic events due to a hypercoagulable state caused by several factors. The case of a 59‑year‑old woman affected by hypertension and metabolic disorders, treated for a COVID‑19 infection who developed cardiac symptoms during the first days of hospitalization is reported. Electrocardiogram analysis and cardiac‑ultrasound confirmed ST‑segment elevation myocardial infarction (STEMI) diagnosis, thus the patient underwent percutaneous coronary intervention, which was successful. This case highlights a possible association between respiratory infection, particularly SARS‑CoV‑2 infection, and cardiovascular events, in particular Acute Coronary Syndrome. The association between these phenomena seems related to a range of factors, including a proinflammatory state and the hypoxemia. Moreover, the association amongst SARS‑CoV‑2 and cardiovascular diseases may be also linked to long‑term sequelae. Thus, further studies are required to better understand the multifaceted and severe complications of this disease.

View Figures

View References

1	Marino A, Pampaloni A, Scuderi D, Cosentino F, Moscatt V, Ceccarelli M, Gussio M, Celesia BM, Bruno R, Borraccino S, et al: High flow nasal cannula oxygenation and tocilizumab administration in patients critically ill with COVID 19: A report of three cases and a literature review. World Acad Sci J. 2:1. 2020.
2	Marino A, Cosentino F, Pampaloni A, Scuderi D, Moscatt V, Gussio M, Onorante A, Zagami A, Torrisi S, Grasso S, et al: Role of tocilizumab and high flow nasal cannula in the clinical management of severe Covid 19. J Clin Trials. 10(427)2020.
3	Spiezia L, Boscolo A, Poletto F, Cerruti L, Tiberio I, Campello E, Navalesi P and Simioni P: COVID-19-Related Severe Hypercoagulability in Patients Admitted to Intensive Care Unit for Acute Respiratory Failure. Thromb Haemost. 120:998–1000. 2020.PubMed/NCBI View Article : Google Scholar
4	Ceccarelli M, Berretta M, Venanzi Rullo E, Nunnari G and Cacopardo B: Differences and similarities between Severe Acute Respiratory Syndrome (SARS)-CoronaVirus (CoV) and SARS-CoV-2. Would a rose by another name smell as sweet? Eur Rev Med Pharmacol Sci. 24:2781–2783. 2020.PubMed/NCBI View Article : Google Scholar
5	Setti L, Kirienko M, Dalto SC, Bonacina M and Bombardieri E: FDG-PET/CT findings highly suspicious for COVID-19 in an Italian case series of asymptomatic patients. Eur J Nucl Med Mol Imaging. 47:1649–1656. 2020.PubMed/NCBI View Article : Google Scholar
6	Aghagoli G, Gallo Marin B, Soliman LB and Sellke FW: Cardiac involvement in COVID-19 patients: Risk factors, predictors, and complications: A review. J Card Surg. 35:1302–1305. 2020.PubMed/NCBI View Article : Google Scholar
7	Inciardi RM, Lupi L, Zaccone G, Italia L, Raffo M, Tomasoni D, Cani DS, Cerini M, Farina D, Gavazzi E, et al: Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 5:819–824. 2020.PubMed/NCBI View Article : Google Scholar
8	Katia F, Myriam DP, Ucciferri C, Auricchio A, Di Nicola M, Marchioni M, Eleonora C, Emanuela S, Cipollone F and Vecchiet J: Efficacy of canakinumab in mild or severe COVID-19 pneumonia. Immun Inflamm Dis. 9:399–405. 2021.PubMed/NCBI View Article : Google Scholar
9	D'Ardes D, Pontolillo M, Esposito L, Masciarelli M, Boccatonda A, Rossi I, Bucci M, Guagnano MT, Ucciferri C, Santilli F, et al: Duration of COVID-19: Data from an Italian Cohort and Potential Role for Steroids. Microorganisms. 8(1327)2020.PubMed/NCBI View Article : Google Scholar
10	Ucciferri C, Vecchiet J and Falasca K: Role of monoclonal antibody drugs in the treatment of COVID-19. World J Clin Cases. 8:4280–4285. 2020.PubMed/NCBI View Article : Google Scholar
11	Beigel JH: JH. What is the role of remdesivir in patients with COVID-19? Curr Opin Crit Care. 27:487–492. 2021.PubMed/NCBI View Article : Google Scholar
12	Sadiq Z, Rana S, Mahfoud Z and Raoof A: Systematic review and meta-analysis of chest radiograph (CXR) findings in COVID-19. Clin Imaging. 80:229–238. 2021.PubMed/NCBI View Article : Google Scholar
13	Pang C, Hou Q, Yang Z and Ren L: Chest computed tomography as a primary tool in COVID-19 detection: An update meta-analysis. Clin Transl Imaging. 9:341–351. 2021.PubMed/NCBI View Article : Google Scholar
14	Loghin C, Chauhan S and Lawless SM: Pseudo-Acute Myocardial Infarction in a Young COVID-19 Patient. JACC Case Rep. 2:1284–1288. 2020.PubMed/NCBI View Article : Google Scholar
15	Chapman AR, Bularga A and Mills NL: High-Sensitivity Cardiac Troponin Can Be an Ally in the Fight Against COVID-19. Circulation. 141:1733–1735. 2020.PubMed/NCBI View Article : Google Scholar
16	Musher DM, Abers MS and Corrales-Medina VF: Acute Infection and Myocardial Infarction. N Engl J Med. 380:171–176. 2019.PubMed/NCBI View Article : Google Scholar
17	Mihatov N, Januzzi JL Jr and Gaggin HK: Type 2 myocardial infarction due to supply-demand mismatch. Trends Cardiovasc Med. 27:408–417. 2017.PubMed/NCBI View Article : Google Scholar
18	Sandoval Y and Jaffe AS: Type 2 Myocardial Infarction: JACC Review Topic of the Week. J Am Coll Cardiol. 73:1846–1860. 2019.PubMed/NCBI View Article : Google Scholar
19	Schiavone M, Gobbi C, Biondi-Zoccai G, D'Ascenzo F, Palazzuoli A, Gasperetti A, Mitacchione G, Viecca M, Galli M, Fedele F, et al: Acute Coronary Syndromes and Covid-19: Exploring the Uncertainties. J Clin Med. 9(1683)2020.PubMed/NCBI View Article : Google Scholar
20	Marino A, Munafò A, Zagami A, Ceccarelli M, Di Mauro R, Cantarella G, Bernardini R, Nunnari G and Cacopardo B: Ampicillin Plus Ceftriaxone Regimen against Enterococcus faecalis Endocarditis: A Literature Review. J Clin Med. 10(4594)2021.PubMed/NCBI View Article : Google Scholar
21	Cevik M, Tate M, Lloyd O, Maraolo AE, Schafers J and Ho A: SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: A systematic review and meta-analysis. Lancet Microbe. 2:e13–e22. 2021.PubMed/NCBI View Article : Google Scholar
22	Yan D, Zhang X, Chen C, Jiang D, Liu X, Zhou Y, Huang C, Zhou Y, Guan Z, Ding C, et al: Characteristics of Viral Shedding Time in SARS-CoV-2 Infections: A Systematic Review and Meta-Analysis. Front Public Health. 9(652842)2021.PubMed/NCBI View Article : Google Scholar
23	Lo IL, Lio CF, Cheong HH, Lei CI, Cheong TH, Zhong X, Tian Y and Sin NN: IL. Evaluation of SARS-CoV-2 RNA shedding in clinical specimens and clinical characteristics of 10 patients with COVID-19 in Macau. Int J Biol Sci. 16:1698–1707. 2020.PubMed/NCBI View Article : Google Scholar
24	Zhou B, She J, Wang Y and Ma X: Duration of Viral Shedding of Discharged Patients With Severe COVID-19. Clin Infect Dis. 71:2240–2242. 2020.PubMed/NCBI View Article : Google Scholar
25	Stefanini GG, Montorfano M, Trabattoni D, Andreini D, Ferrante G, Ancona M, Metra M, Curello S, Maffeo D, Pero G, et al: ST-Elevation Myocardial Infarction in Patients With COVID-19: Clinical and Angiographic Outcomes. Circulation. 141:2113–2116. 2020.PubMed/NCBI View Article : Google Scholar
26	Stoltzfus KB, Bhakta M, Shankweiler C, Mount RR and Gibson C: Appropriate utilisation of cardiac telemetry monitoring: A quality improvement project. BMJ Open Qual. 8(e000560)2019.PubMed/NCBI View Article : Google Scholar
27	Campanella E, Marino A, Urso S, Insalaco M, Emmanuele C, Uccello G, Cosentino F, Moscatt V, Ceccarelli M, Caruso A, et al: The role of the SARS-COV 2 pandemic on the delay of diagnosis in a case of multiple myeloma associated with AL amyloidosis in HIV-HBV positive patient on antiretroviral treatment. Eur J Mol Clin Med (Lond). 8:3564–3569. 2021.